AAAAAA

   
Results: 1-3 |
Results: 3
THE SAFETY AND TOLERANCE OF XANOMELINE TARTRATE, AN M1-SPECIFIC CHOLINERGIC AGONIST, IN PATIENTS WITH ALZHEIMERS-DISEASE
Authors: CUTLER NR SRAMEK JJ SEIFERT RD CONRAD JJ WARDLE TS DIES F HURLEY DJ THOREN LM
Citation: Nr. Cutler et al., THE SAFETY AND TOLERANCE OF XANOMELINE TARTRATE, AN M1-SPECIFIC CHOLINERGIC AGONIST, IN PATIENTS WITH ALZHEIMERS-DISEASE, Neurobiology of aging, 15, 1994, pp. 190000104-190000104
THE SAFETY AND TOLERANCE OF XANOMELINE TARTRATE, A M(1)-SPECIFIC CHOLINERGIC AGONIST, IN PATIENTS WITH ALZHEIMERS-DISEASE
Authors: SRAMEK JJ CUTLER NR SEIFERT RD CONRAD JJ WARDLE TS HURLEY DJ THOREN LM
Citation: Jj. Sramek et al., THE SAFETY AND TOLERANCE OF XANOMELINE TARTRATE, A M(1)-SPECIFIC CHOLINERGIC AGONIST, IN PATIENTS WITH ALZHEIMERS-DISEASE, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 174-174
A BRIDGING STUDY OF XANOMELINE TARTRATE IN ALZHEIMERS-DISEASE (AD)
Authors: CUTLER NR SRAMEK JJ SEIFERT RD CONRAD JJ WARDLE TS HURLEY DJ THOREN LM
Citation: Nr. Cutler et al., A BRIDGING STUDY OF XANOMELINE TARTRATE IN ALZHEIMERS-DISEASE (AD), Biological psychiatry, 35(9), 1994, pp. 628-628
Risultati: 1-3 |